NIH Locks Doors for Minority Health Grant Gossip
Published Date: 3/18/2025
Notice
Summary
The National Institute on Minority Health and Health Disparities is holding several closed virtual meetings in April 2025 to review grant applications aimed at improving health equity for minority and underserved communities. These meetings affect researchers seeking funding and help decide who gets money to support important health projects. The process keeps sensitive information private while moving forward on funding decisions that could impact health research and careers.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Which Grants Are Being Reviewed
NIMHD will review and evaluate grant applications for specific programs in April 2025, including: Model Continuums of Care Initiative (Apr 15-17), Mentored Career and Research Development Awards (Ks) (Apr 16-18), Research Centers in Minority Institutions (RCMI) (Apr 21-25), HIV-related comorbidities interventions (Apr 21-25), Technologies/Innovations for Improving Minority Health (Apr 28-30), and Support for Conferences and Scientific Meetings (R13) (Apr 30). These reviews decide who receives funding.
Grant Reviews Closed to the Public
The National Institute on Minority Health and Health Disparities will hold multiple virtual grant-review meetings in April 2025 that are closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because applications may disclose confidential trade secrets and personal information. Meetings include sessions April 15-17, April 16-18, April 21-25, April 28-30, and April 30, 2025.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the Office of Laboratory Animal Welfare (OLAW) in the Office of Extramural Research (OER) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
Previous / Next Documents
Previous: 2025-04405, Data Collection Available for Public Comments
The Small Business Administration wants your thoughts on a new data collection plan before they ask for official approval. This affects small businesses who might need to share info, but it’s all about making things easier and clearer. You’ve got a chance to speak up soon, so don’t miss out!
Next: 2025-04408, Data Collection Available for Public Comments
The Small Business Administration wants your thoughts on a new data collection plan before they ask for official approval. This affects small businesses who might need to share some info, but no big money changes are expected. You’ve got a chance to speak up soon, so don’t miss out!